Eva König wins Heribert-Konzett-Prize!
A great success! Dr. Eva König, principal investigator at St. Anna CCRI, is honored with the Heribert-Konzett-Prize of the Austrian Pharmacological Society (APHAR) for her scientific work on the interaction between immune and cancer cells. The prize is awarded to recognize the achievements of young scientists already conducting independent research in the field of experimental and clinical pharmacology and to encourage their further development.
Two St. Anna CCRI projects selected for FWF’s 1000 ideas program
This year’s 1000 ideas program of FWF promotes another two of St. Anna CCRI’s “completely new, daring or particularly original research ideas that lie outside the current scientific understanding”. Florian Halbritter’s new approach aims to integrate machine learning directly into the experimental design and execution of manufacturing specific cell types from stem cells – with the ultimate goal to reprogram even cancer cells. Artem Kalinichenko, who was also awarded a 1000 ideas grant, is targeting abnormal tumor metabolism by identifying cancer-derived metabolites, drugs and drug metabolites that trigger an immune reaction, which could later be exploited for immunotherapy.
11TH UDNI CONFERENCE: WIEN (AUSTRIA) NOVEMBER 7-8, 2022 – Save the Date!
Our partner institution, the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases is happy to host the 11th International Conference of the Undiagnosed Diseases Network International (UDNI), which will take place from November 7th to 8th in the Van Swieten Saal of the Medical University of Vienna Vienna, as a hybrid event.
When: Monday, 07.11. – Tuesday, 08.11.2022
Organizer: Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases (LBI-RUD)
Children´s Cancer Research Institute
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Medical University of Vienna